We provide you with 20 years of free, institutional-grade data for LHDX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LHDX. Explore the full financial landscape of LHDX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about LHDX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lucira Health, Inc(NASDAQ:LHDX) 
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops infl...
Website: http://www.lucirahealth.com
Founded: 2013
Full Time Employees: 71 (May 2021)
CEO: Erik Engelson
Sector: Healthcare
Industry: Diagnostics & Research
Share this website to your friends